Heavy Insider Selling Alert! Guess? Inc. (GES), Mentor Graphics Corp (MENT), and Monsanto Company (MON)

Page 2 of 2

Mentor Graphics Corp (NASDAQ:MENT) has seen three different insiders offload shares over the past few months, but we will stick to the most recent transactions. Walden C. Rhines, Chairman of the Board and Chief Executive Officer, unloaded 20,000 shares this Monday and 150,000 shares last week at prices ranging from $25.55 to $25.86. Following these transactions, the executive holds 195,336 shares. The leader in electronic design automation has seen its stock advance by over 17% since the beginning of the year, greatly outperforming the broader market. Exactly a month ago, Mentor Graphics Corp (NASDAQ:MENT) announced the acquisition of its majority-owned subsidiary Calypto Design Systems Inc., which now represents a new standalone business unit of the company. This step revealed the company’s confidence in the future potential of Calypto’s products and technologies, which might in turn provide significant benefits for the company itself. In the meantime, Carl Icahn of Icahn Capital LP put his faith in Mentor Graphics Corp (NASDAQ:MENT), disclosing a 16.12 million-share stake in the company through the 13F filing for the June quarter.

Follow Mentor Graphics Corp (NASDAQ:MENT)

Lastly, the agriculture company Monsanto Company (NYSE:MON) also saw one of its insiders sell stock recently. Steven C. Mizell, Executive Vice President of Human Resources, reported selling 6,100 shares this Tuesday at a weighted average price of $89.40 per unit, trimming his stake to 9,374 shares. The executive also owns 976 shares through a retirement savings plan. Just recently, Monsanto Company (NYSE:MON) announced an accelerated share repurchase (ASR) program under which the company is set to buy back $3 billion worth of common stock. This surely indicates that the company’s management believes that the stock is currently trading at an attractive level. In fact, the stock has lost 24% since the beginning of the year. However, numerous lawsuits have been filed against the agriculture company claiming that its Roundup herbicide has instigated cancer in people exposed to this chemical product. Roundup generated revenues of roughly $4.8 billion for Monsanto in fiscal 2015, so the recent allegations might put downward pressure on the company’s stock performance and top-line as well. Larry Robbins’ Glenview Capital is by far the largest stockholder of Monsanto Company (NYSE:MON) within our database, holding 11.07 million shares.

Follow Monsanto Co W (NYSE:MON)

Disclosure: None

Page 2 of 2